Wearable Devices Ltd Secures US Patent for Gesture and Biometric Authentication

scanx
Reviewed by
Naman SScanX News Team
Key Highlights

Wearable Devices Ltd has expanded its IP portfolio with a new USPTO continuation patent issued on August 11, 2026. The patent covers a gesture interface that uses biopotential sensors to record neural signals, enabling accurate user authentication by clustering personalized gesture signatures. This strengthens the company's position in AI-powered touchless sensing wearables.

powered bylight_fuzz_icon
47681498

*this image is generated using AI for illustrative purposes only.

Wearable Devices Ltd (NASDAQ: WLDS) has been granted a new continuation patent by the United States Patent and Trademark Office (USPTO), expanding its intellectual property protections in the wearable technology sector. The patent, issued on August 11, 2026, falls under the company’s foundational patent family titled "Gesture and Voice-Controlled Interface Device." This development specifically covers technologies that authenticate users based on a combination of gestures and unique biological signals, enabling secure payments, user detection, and authorized actions.

The newly granted claims describe a gesture interface device and method that integrate gesture sensors with biopotential sensors. When worn, the device records neural signals alongside physical movements. The system’s processor analyzes these sensed gestures against a personalized gesture signature, building a gesture metric space that clusters gestures belonging to the same user while separating those of different users. This mechanism enables highly accurate user verification, distinguishing it from standard gesture-only controls.

Patent Details

The following details pertain to the newly issued continuation patent:

Metric Value
Patent Family Title Gesture and Voice-Controlled Interface Device
Issuance Date August 11, 2026
Jurisdiction United States
Key Feature Biometric authentication via neural signals
Company Ticker NASDAQ: WLDS

This grant complements Wearable Devices Ltd’s earlier U.S. Patent Number 12,704,907, which secured rights for a general "Gesture and Voice Controlled Interface Device." While the initial patent established legal barriers against competitors replicating the multimodal interaction system, this new continuation patent adds a layer of security by incorporating biometric data. The company specializes in artificial intelligence-powered touchless sensing wearables, and this IP expansion reinforces its position in the market.

Strategic Implications

Securing this continuation patent strengthens Wearable Devices Ltd’s proprietary technology portfolio by validating the technical novelty of its biometric integration. The ability to authenticate users through unique biological signals recorded via biopotential sensors provides a robust security feature for consumer applications. This exclusivity allows the company to manufacture, use, and sell devices with this specific verification capability within the United States without fear of direct replication.

The focus on combining gesture control with neural signal analysis aligns with industry trends toward more intuitive and secure hands-free interactions. By differentiating its product offerings from competitors relying on traditional touch-based or single-mode input systems, Wearable Devices Ltd enhances its competitive positioning. This intellectual property asset may also serve as a foundation for future licensing opportunities or cross-licensing negotiations with other technology firms seeking advanced authentication solutions.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might the integration of neural signal biometrics impact consumer privacy regulations and data protection standards in the wearable tech sector?

What is the estimated timeline for Wearable Devices Ltd to commercialize products utilizing this new biometric authentication patent?

Could this IP expansion position WLDS for strategic licensing deals with major smartphone or smartwatch manufacturers seeking enhanced security features?

like18
dislike

Wearable Devices raises $3.3M in private placement for AI6 Labs expansion

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

Wearable Devices Ltd. secured $3.3 million in gross proceeds from a single institutional investor through a private placement priced at $3.285 per share and warrant. The funds are designated for AI6 Labs expansion, Mudra device commercialization, and general corporate needs, with closing expected on August 3, 2026.

powered bylight_fuzz_icon
47046144

*this image is generated using AI for illustrative purposes only.

Wearable Devices Ltd. (NASDAQ: WLDS) announced on July 31, 2026, that it has entered into a securities purchase agreement to raise approximately $3.3 million in gross proceeds through a private placement of ordinary shares and warrants. The transaction involves the sale of 1,000,000 ordinary shares and warrants to purchase up to 1,000,000 additional shares to a single institutional investor at a combined price of $3.285 per share and warrant. This capital infusion is designed to accelerate the company’s strategic focus on AI-powered touchless sensing technologies, specifically funding its AI6 Labs initiatives and the commercialization of its Mudra product line.

The offering was priced at-the-market under Nasdaq rules and above the last closing price. The warrants issued carry an exercise price of $3.16 per share, are exercisable immediately upon issuance, and will expire five years following the date of issuance. A.G.P./Alliance Global Partners is acting as the sole placement agent for the transaction. The closing of the offering is expected to occur on or about August 3, 2026, subject to customary closing conditions.

Offering Component Details
Gross Proceeds $3.3 million
Shares Sold 1,000,000 ordinary shares
Warrants Issued Up to 1,000,000 ordinary shares
Price Per Unit $3.285 (share + warrant)
Warrant Exercise Price $3.16 per share
Warrant Expiry Five years from issuance
Closing Date On or about August 3, 2026

The company stated that net proceeds will be deployed for several key growth initiatives. Primary uses include the continued commercialization of Mudra products, such as the Mudra Band and Mudra Link devices designed for touch-free control of digital systems. Funds will also support the development and manufacturing of next-generation product lines and the advancement of AI6 Labs initiatives within the Physical AI and Robotics vertical. Additionally, the capital may be used for potential strategic transactions, working capital, and other general corporate purposes.

Regulatory Framework

The offer and sale of these securities are being made in reliance on an exemption from registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Regulation D promulgated thereunder, along with applicable state securities laws. Consequently, the securities have not been and will not initially be registered under the Securities Act or applicable state securities laws. Pursuant to the securities purchase agreement, Wearable Devices has agreed to file a registration statement with the U.S. Securities and Exchange Commission covering the resale of the ordinary shares and the ordinary shares underlying the common warrants sold in this offering.

Strategic Implications

The influx of capital underscores Wearable Devices’ commitment to scaling its dual-channel business model, which combines direct-to-consumer sales with enterprise licensing. By funding the AI6 Labs ecosystem, the company aims to integrate research, products, and AI breakthroughs to enhance its position in the XR ecosystem. This move allows the firm to address both consumer needs for stylish, functional wearables in gaming and productivity, and enterprise demands for advanced input solutions in immersive environments. The ability to close this transaction quickly with a single institutional investor suggests strong market confidence in the company’s technology roadmap and its proprietary neural input touchless technology.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might the dilution from issuing 1,000,000 new shares and warrants impact Wearable Devices' earnings per share and shareholder value in the near term?

What specific milestones or revenue targets must the Mudra product line achieve to justify the capital allocation toward its commercialization?

Could the immediate exercisability of the warrants create downward pressure on WLDS stock price if the market price exceeds the $3.16 exercise price shortly after closing?

like16
dislike

More News on Wearable Devices Ltd